Leukemia Posts on Medivizor
Navigation Menu

Leukemia Posts on Medivizor

Kidney problems and anemia linked with imatinib use in chronic myeloid leukemia

Posted by on Feb 20, 2019 in Leukemia | 0 comments

In a nutshell This study looked at the effect of imatinib (Gleevec) on kidney function in patients with chronic myeloid leukemia (CML). Researchers found that a reversible decline in kidney function was linked with long-term imatinib use in these patients. Some background Imatinib is a strong drug used to treat CML. The kidney produces a hormone that...

Read More

Allogenic hematopoietic stem cell transplantation as treatment for patients with BCR-ABL1-negative atypical chronic myeloid leukemia

Posted by on Feb 17, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if allogeneic hematopoietic stem cell transplant is an effective treatment for atypical chronic myeloid leukemia. This study concluded that this treatment is effective in these patients. Some background Atypical chronic myeloid leukemia (aCML) and chronic neutrophilic leukemia (CNL) are cancers...

Read More

Is venetoclax with decitabine or azacitidine effective in treating elderly patients with acute myeloid leukemia?

Posted by on Feb 16, 2019 in Leukemia | 0 comments

In a nutshell This study examined If venetoclax (Venclexta) with decitabine (Dacogen) or azacitidine (Vidaza) is effective in treating elderly patients with acute myeloid leukemia (AML).  This study concluded that venetoclax with decitabine or azacitidine could be an effective treatment in these patients.  Some background Acute...

Read More

Oncolytic Virus Treatments

Oncolytic Virus Treatments

Posted by on Feb 10, 2019 in Blog, Breast cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 0 comments

In 1904, a physician wrote about a patient with leukemia who went into remission when he got the flu. Though the patient was not cured, it was a ray of hope at a time when there were no treatments for leukemia. Other cases were reported throughout the years of people with Burkitt’s Lymphoma and Hodgkin’s Lymphoma going into remission when they...

Read More

Evaluating nilotinib with chemotherapy for acute lymphoblastic leukemia with abnormal genes

Posted by on Jan 31, 2019 in Leukemia | 0 comments

In a nutshell This study wanted to assess the safety and effectiveness of nilotinib (Tasigna) in the treatment of acute lymphoblastic leukemia (ALL) with abnormal genes. Researchers found that nilotinib was safe and effective in these patients when combined with chemotherapy. Some background Acute lymphoblastic leukemia (ALL) is a cancer of the immune...

Read More

Comparing ibrutinib and ofatumumab in patients with previously treated chronic lymphocytic leukemia

Posted by on Jan 28, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate patient well-being and patient-reported outcomes in previously treated patients with chronic lymphocytic leukemia who receive ibrutinib (Imbruvica) or ofatumumab (Arzerra). They concluded that ibrutinib can improve quality of life while prolonging survival in these patients. Some background...

Read More